HBI Deals+Insights / M&A/IPOs
Two of Europe’s biggest healthcare companies which were widely expected to IPO imminently are now, we hear, ruling out this year. Why the delay – and what does this tell us about the state of a slowing market? HBI speaks to an operator CEO and investment banking sources.